{
    "key": "2016-0023",
    "name": "Adolescent child age 11 with 2nd dose of HPV at 5 months - 5 days",
    "cdcTestId": "2016-0023",
    "changedInVersion": "3.2",
    "dateAdded": "2016-12-02T00:00:00",
    "dateUpdated": "2020-06-15T09:11:50.871",
    "evaluation": {
        "administeredDoses": [
            {
                "cvx": "165",
                "dateAdministered": "2020-03-18T00:00:00",
                "evaluationReason": "",
                "evaluationStatus": "Valid",
                "mvx": "MSD",
                "vaccineName": "Gardasil 9"
            },
            {
                "cvx": "165",
                "dateAdministered": "2020-08-13T00:00:00",
                "evaluationReason": "",
                "evaluationStatus": "Valid",
                "mvx": "",
                "vaccineName": "HPV9"
            }
        ],
        "seriesStatus": "Not complete"
    },
    "evaluationTestType": "Interval: Below Absolute Minimum",
    "forecast": {
        "earliestDate": "2020-11-05T00:00:00",
        "forecastNum": "3",
        "pastDueDate": "2021-05-15T00:00:00",
        "recommendedDate": "2020-11-05T00:00:00"
    },
    "forecastTestType": "Recommended based on interval",
    "generalDescription": "This test case describes when a second dose is administered at an interval of 4 weeks -4 days but before 5 months that a repeat dose  should be forecasted.",
    "patient": {
        "dob": "2009-01-29T00:00:00",
        "gender": "F",
        "medHistoryCode": "",
        "medHistoryCodeSys": "",
        "medHistoryText": "",
        "doses": [
            {
                "cvx": "165",
                "dateAdministered": "2020-03-18T00:00:00",
                "evaluationReason": "",
                "evaluationStatus": "Valid",
                "mvx": "MSD",
                "vaccineName": "Gardasil 9"
            },
            {
                "cvx": "165",
                "dateAdministered": "2020-08-13T00:00:00",
                "evaluationReason": "",
                "evaluationStatus": "Valid",
                "mvx": "",
                "vaccineName": "HPV9"
            }
        ]
    },
    "reasonForChange": "Updated to reflect current ACIP recommendations for forecasting of the earliest and recommended date which is set by 12 weeks from invalid dose.",
    "testcaseName": "Adolescent child age 11 with 2nd dose of HPV at 5 months - 5 days",
    "vaccineGroup": "HPV"
}